Clinical Trial Update: Effect of Lactobacillus Reuteri in Cystic Fibrosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of Lactobacillus reuteri in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Azienda Policlinico Umberto I | Conditions: CYSTIC FIBROSIS | Phase 4 | Status: COMPLETED